Otezla (apremilast) is a brand-name tablet prescribed for psoriatic arthritis, plaque psoriasis, and mouth ulcers due to Behçet’s disease. As with other drugs, Otezla can cause side effects ...

Dallas is an Otezla patient who has been compensated for his time. Courtesy of Amgen Inc. Plaque psoriasis is a fairly common autoimmune skin condition — as many as 6.7 million people in the US ...

aiming to mount a challenge to Amgen's $2.3 billion oral psoriasis therapy Otezla (apremilast). BMS has previously said it reckons Sotyktu could become a $4 billion seller at its peak, fuelled by ...

Amgen has won FDA approval for a stronger label for its oral plaque psoriasis therapy Otezla, as it prepares for competition from Bristol-Myers Squibb's much-touted rival deucravacitinib ...